Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia

Recruiting

Phase 1

TreprostinilInhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia

Sponsor:

Bastiaan Driehuys

Code:

NCT07037836

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Hypoxemia

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Inhaled Treprostinil (Tyvaso Nebulizer)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-26. This information was provided to ClinicalTrials.gov by Bastiaan Driehuys on 2025-10-23.